BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 2 |
Tesla
TSLA
|
+$468M |
| 3 |
AbbVie
ABBV
|
+$312M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$266M |
| 5 |
Abbott
ABT
|
+$254M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$609M |
| 2 |
Apple
AAPL
|
+$577M |
| 3 |
Visa
V
|
+$476M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$434M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.37% |
| 2 | Financials | 8.23% |
| 3 | Consumer Discretionary | 6.83% |
| 4 | Healthcare | 6.12% |
| 5 | Communication Services | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
PUT
Vipshop
VIPS
$6.94B
| $14.1K | ﹤0.01% |
+7
| New | +$176 |
|
|
LJPC
3502
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $13.9K | ﹤0.01% |
3,248
+476
| +17% | +$2.04K |
|
3503
CytomX Therapeutics
CTMX
$760M
| $13.9K | ﹤0.01% |
2,193
-14,736
| -87% | -$115K |
|
|
EXTN
3504
DELISTED
Exterran Corporation
EXTN
| $13.9K | ﹤0.01% |
2,912
-11,847
| -80% | -$50.7K |
|
3505
Oramed Pharmaceuticals
ORMP
$178M
| $13.8K | ﹤0.01% |
+1,029
| New | +$11.8K |
|
3506
Vanguard Morningstar Value ETF
VTV
$193B
| $13.7K | ﹤0.01% |
+100
| New | +$13.7K |
|
|
ENZ
3507
DELISTED
Enzo Biochem, Inc.
ENZ
| $13.6K | ﹤0.01% |
4,282
-13,656
| -76% | -$42.9K |
|
|
CASA
3508
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $13.6K | ﹤0.01% |
1,528
-3,353
| -69% | -$29.7K |
|
3509
AgEagle Aerial Systems
UAVS
$55.5M
| $13.5K | ﹤0.01% |
+3
| New | +$16.5K |
|
3510
Allient
ALNT
$1.94B
| $13.5K | ﹤0.01% |
392
-1,372
| -78% | -$48.3K |
|
3511
Identive
INVE
$63.4M
| $13.5K | ﹤0.01% |
+796
| New | +$12K |
|
3512
Vitamin Cottage Natural Grocers
NGVC
$632M
| $13.5K | ﹤0.01% |
1,257
-1,058
| -46% | -$14.3K |
|
3513
InfuSystem Holdings
INFU
$244M
| $13.4K | ﹤0.01% |
646
-1,209
| -65% | -$24.4K |
|
3514
Ovid Therapeutics
OVID
$489M
| $13.4K | ﹤0.01% |
3,434
-2,440
| -42% | -$9.63K |
|
3515
LiveOne
LVO
$55.5M
| $13.3K | ﹤0.01% |
283
-1,701
| -86% | -$73.8K |
|
|
MFGP
3516
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $13.3K | ﹤0.01% |
1,769
| – | – |
|
3517
Spero Therapeutics
SPRO
$68.9M
| $13.2K | ﹤0.01% |
947
-13,382
| -93% | -$187K |
|
3518
Pure Cycle
PCYO
$273M
| $13.2K | ﹤0.01% |
956
-1,447
| -60% | -$20.7K |
|
3519
Meridian
MRBK
$238M
| $13.1K | ﹤0.01% |
998
-3,540
| -78% | -$46.5K |
|
|
RVLP
3520
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $13.1K | ﹤0.01% |
4,347
-526
| -11% | -$1.61K |
|
|
DS
3521
DELISTED
Drive Shack Inc.
DS
| $13.1K | ﹤0.01% |
3,950
+2,476
| +168% | +$7.93K |
|
3522
Televisa
TV
$1.49B
| $13.1K | ﹤0.01% |
914
-60,400
| -99% | -$776K |
|
3523
American Realty Investors
ARL
$243M
| $13K | ﹤0.01% |
1,393
-956
| -41% | -$9.24K |
|
3524
Limoneira
LMNR
$251M
| $12.9K | ﹤0.01% |
735
-4,469
| -86% | -$81.9K |
|
3525
Comp X International
CIX
$386M
| $12.9K | ﹤0.01% |
619
-569
| -48% | -$12.5K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2021 Portfolio in Review
As of Q2 2021, BNP Paribas Financial Markets held 4,172 positions worth $75.6B, up 11% from $68.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
BNP Paribas Financial Markets's Q2 2021 filing shows 175 new, 1,539 increased, 1,937 reduced and 124 closed positions. Its largest new stake was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M. The largest sale was Invesco QQQ Trust, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2021 buy was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $1.06B increase.
- BNP Paribas Financial Markets's biggest Q2 2021 reduction was Invesco QQQ Trust, cutting an estimated $609M.
- BNP Paribas Financial Markets fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $123M.
- BNP Paribas Financial Markets's ten largest holdings make up 13% of its $75.6B portfolio in Q2 2021.
- BNP Paribas Financial Markets opened 175 new positions and closed 124 in Q2 2021.
- BNP Paribas Financial Markets's portfolio value rose 11% quarter-over-quarter to $75.6B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2021, filed 10 Aug 2021.